The FDA is adopting agentic AI tools to streamline pre-market reviews and administrative tasks. Although intended to enhance efficiency, there are concerns regarding the unpredictable behavior of AI in regulatory contexts, particularly regarding safety and effectiveness assessments in various health-related fields.